Breaking News
Get 50% Off 0
📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-Earnings Read more
Close

DiaSorin SpA (34D)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
101.050 +0.100    +0.10%
19/07 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  IT0003492391 
S/N:  A0MTB2
  • Volume: 1
  • Bid/Ask: 102.100 / 103.000
  • Day's Range: 101.050 - 101.050
Diasorin 101.050 +0.100 +0.10%

BIT:34D Financials

 
A brief overview of the BIT:DIAS financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of DiaSorin SpA over time.

DiaSorin S.p.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 289 million compared to EUR 290 million a year ago. Net income was EUR 46 million compared to EUR 42 million a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

34D Income Statement

Gross margin TTM 64.61%
Operating margin TTM 19.92%
Net Profit margin TTM 14.28%
Return on Investment TTM 6.97%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 302.21 270 286.79 289.6
Gross Profit 195.19 168 186.78 191.9
Operating Income 55.51 49 60.13 65.1
Net Income 47.85 25 46.42 41.7

34D Balance Sheet

Quick Ratio MRQ 1.8
Current Ratio MRQ -
LT Debt to Equity MRQ 46.29%
Total Debt to Equity MRQ 46.29%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 3211.44 2928 3204.56 3046.1
Total Liabilities 1673.47 1374 1708.91 1518.9
Total Equity 1537.97 1554 1495.65 1527.2

34D Cash Flow Statement

Cash Flow/Share TTM 6.49
Revenue/Share TTM 21.53
Operating Cash Flow  26.76%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 85.66 80 104.44 41.2
Cash From Investing Activities -87.1 -49 125.38 -17.6
Cash From Financing Activities 47.04 -44 -302.78 68
Net Change in Cash 37.54 -13 -116.29 130.8
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DIAS Comments

Write your thoughts about DiaSorin SpA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Massimo Salvadori
Massimo Salvadori May 15, 2024 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rottura della Resistenza avvenuta...pull in atto non appena supera il massimo della giornata precedente naturalmente senza apertura in gap si entra pesanti
Alessandro To
Alessandro To Apr 13, 2023 12:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
E comunwue oggi incremento . Bilanci dal 2020 raddoppiati.
Tobias Raeder
Tobias Raeder Jun 02, 2021 10:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Che successe, mentre il resto sale?
Tobias Raeder
Tobias Raeder Jun 02, 2021 10:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
superata la curva alta di Bollinger,  punta a 160 ?
Robin Clerici
Robin Clerici Jun 02, 2021 10:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tobias Raeder well said! It did it now
Jhon Lucy
Jhon Lucy May 26, 2020 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Overrated company, in my opinion you can sell Short Diasorin capitalization 11 billion euros Profits 175 million euros Turnover 800 million ISIN IT0003492391 diasorin
Saverio Daquino
Saverio Daquino May 25, 2020 2:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
short!!
giulio corsi
giucor Apr 25, 2020 11:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
alla faccia del fattoquotidiano che oggi ha provato a dare un'altra spallata a questo gioiello... Coronavirus: da Fda via libera a test sierologico DiaSorin L'autorizzazione per analisi validata al San Matteo di Pavia (ANSA) - ROMA, 25 APR - DiaSorin annuncia di aver ricevuto l'Emergency Use Authorization (EUA) dalla Food and Drug Administration americana per il test LIAISON  SARS-CoV-2 S1/S2 IgG. Si tratta del nuovo test sierologico validato presso il Policlinico San Matteo a Pavia, uno dei centri di riferimento nazionali per la pandemia da COVID-19.
Sam Lloyd
Sam Lloyd Mar 20, 2020 3:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DIASORIN COVID fast test has been approved by FDA
luca cas
luca cas Mar 20, 2020 3:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice news, not sure why is going down anyway
Roby Carati
Roby Carati Mar 20, 2020 3:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When??????
Dario Fazio
Dario Fazio Mar 13, 2020 5:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
USA: Dow e NASDAQ han chiuso a +10%. Lunedì si parte da 120.10€. Buon weekend
Captain USD
Captain USD Mar 13, 2020 5:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
E invece... 109.90€ :D
Enea Caccamese
Enea Caccamese Mar 13, 2020 11:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DiaSorin’s test could be ready within six weeks for consideration by the U.S. Food and Drug Administration, and the QIAGEN test could be ready within 12 weeks for FDA consideration, according to HHS.
Sam Lloyd
Sam Lloyd Mar 11, 2020 11:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They just announced a fast test for COVID-19, 60 minutes against some hours
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email